Supplementation with Iron in Pulmonary Arterial Hypertension. Two Randomized Crossover Trials

Rationale: Iron deficiency, in the absence of anemia, is common in patients with idiopathic and heritable pulmonary arterial hypertension (PAH) and is associated with a worse clinical outcome. Oral iron absorption may be impeded by elevated circulating hepcidin concentrations. The safety and benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Howard, Luke S. G. E., He, Jianguo, Watson, Geoffrey M. J., Huang, Li, Wharton, John, Luo, Qin, Kiely, David G., Condliffe, Robin, Pepke-Zaba, Joanna, Morrell, Nicholas W., Sheares, Karen K., Ulrich, Anna, Quan, Ruilin, Zhao, Zhihui, Jing, Xiaoli, An, Chenhong, Liu, Zhihong, Xiong, Changming, Robbins, Peter A., Dawes, Timothy, de Marvao, Antonio, Rhodes, Christopher J., Richter, Manuel J., Gall, Henning, Ghofrani, Hossein A., Zhao, Lan, Huson, Les, Wilkins, Martin R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456720/
https://www.ncbi.nlm.nih.gov/pubmed/33735594
http://dx.doi.org/10.1513/AnnalsATS.202009-1131OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456720/
https://www.ncbi.nlm.nih.gov/pubmed/33735594
http://dx.doi.org/10.1513/AnnalsATS.202009-1131OC

Ejemplares similares